Impaired insulin secretion due to type 1 diabetes lowers serum IGF-1 levels, and improves glycemic control in patients with type 2 diabetes leads to increased IGF-1 levels (36–38). This evidence concerns the gene IGF1 and type 2 diabetes mellitus.